IRIS Accounts Production v25.4.0.155 11003134 director 1.11.24 31.10.25 31.10.25 No description of principal activity 0 0 false true false false true true iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 11003134 2024-10-31 11003134 2025-10-31 11003134 2024-11-01 2025-10-31 11003134 2023-10-31 11003134 2023-11-01 2024-10-31 11003134 2024-10-31 11003134 ns15:EnglandWales 2024-11-01 2025-10-31 11003134 ns14:USDollar 2024-11-01 2025-10-31 11003134 ns10:Director1 2024-11-01 2025-10-31 11003134 ns10:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 11003134 ns10:SmallEntities 2024-11-01 2025-10-31 11003134 ns10:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 11003134 ns10:SmallCompaniesRegimeForDirectorsReport 2024-11-01 2025-10-31 11003134 ns10:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 11003134 ns10:FullAccounts 2024-11-01 2025-10-31 11003134 ns10:RegisteredOffice 2024-11-01 2025-10-31 11003134 ns5:ShareCapital 2025-10-31 11003134 ns5:ShareCapital 2024-10-31 11003134 ns5:SharePremium 2025-10-31 11003134 ns5:SharePremium 2024-10-31 11003134 ns5:CostValuation 2024-10-31 11003134 ns5:CurrentFinancialInstruments 2025-10-31 11003134 ns5:CurrentFinancialInstruments 2024-10-31

REGISTERED NUMBER: 11003134 (England and Wales)

| UNAUDITED FINANCIAL STATEMENTS |

| FOR THE YEAR ENDED 31ST OCTOBER 2025 |

| FOR |

| DHG UK LIFE SCIENCE LTD |

| DHG UK LIFE SCIENCE LTD (REGISTERED NUMBER: 11003134) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST OCTOBER 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| DHG UK LIFE SCIENCE LTD |

COMPANY INFORMATION

FOR THE YEAR ENDED 31ST OCTOBER 2025

| DIRECTOR: | Dr F Darvas

| REGISTERED OFFICE: | 450 Warrington Road

| Culcheth

| Warrington

| Cheshire

| WA3 5QX

| REGISTERED NUMBER: | 11003134 (England and Wales)

| DHG UK LIFE SCIENCE LTD (REGISTERED NUMBER: 11003134) |

BALANCE SHEET

31ST OCTOBER 2025

| 31.10.25 | 31.10.24 |

| Notes | $ | $ | $ | $ |

FIXED ASSETS

Investments | 4 | 871,396 |  | 871,396 |  |

CURRENT ASSETS

Debtors | 5 | 1 |  | 1 |  |

NET CURRENT ASSETS | 1 |  | 1 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 871,397 |  | 871,397 |  |

CAPITAL AND RESERVES

Called up share capital | 2,703 |  | 2,703 |  |

Share premium | 868,694 |  | 868,694 |  |

SHAREHOLDERS' FUNDS | 871,397 |  | 871,397 |  |

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the year ended 31st October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st October 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 2nd February 2026 and were signed by:

Dr F Darvas - Director

| DHG UK LIFE SCIENCE LTD (REGISTERED NUMBER: 11003134) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST OCTOBER 2025

1. | STATUTORY INFORMATION

| DHG UK Life Science Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was NIL (2024 - NIL).

4. | FIXED ASSET INVESTMENTS

| Other

| investments

$ |

| COST

| At 1st November 2024

| and 31st October 2025 | 871,396 |  |

| NET BOOK VALUE

| At 31st October 2025 | 871,396 |  |

| At 31st October 2024 | 871,396 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.10.25 |  | 31.10.24

$ | $ |

| Amounts owed by group undertakings | 1 |  | 1 |  |